Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FURESTEM-CD in Moderately Active Crohn's Disease
NCT02000362Phase 2Unknown
- Sponsor
- Kangstem Biotech
- Start
- Aug 2014
- Primary completion
- Sep 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of furestem-cd in Crohn's disease, sponsored by Kangstem Biotech. Status: unknown.
02
Drugs
furestem-cd
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02000362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02000362.